Get started
REGENXBIO Inc.REGENXBIO Inc.REGENXBIO Inc.

REGENXBIO Inc.

No trades
OverviewFinancialsNewsDocumentsIdeasMindsTechnicalsForecastsSeasonalsOptionsETFs

Market insights

REGENXBIO Breakout of descending channelREGENXBIO NASDAQ:RGNX is gearing up for a big move on its daily chart after holding strong within a multi-month ascending channel. The price action recently pulled back from the top of the channel and has now broken out of a short-term descending channel, indicating that buyers are starting to regain control. The stock is currently sitting right on top of the middle mid-range of the larger ascending channel, which is a key pivot point for a continuation of the rally. If NASDAQ:RGNX can hold this breakout and make a solid move higher, the next major target is that top channel resistance near $14.72.
NASDAQ:RGNXLong
by ledgerdary
#VolatilityWatch - $RGNX Upcoming data + Technical SetupThis year has been full of positive catalysts for RGNX. As RGNX continues to build out their clinical pipeline, data catalyst from upcoming phase 2a report on their Wet-AMD gene therapy product could send the stock roaring higher. RGNX is set to report data Oct. 13, 2019 and the companies technical setup is quite nice. The Wet-AMD market is a lucrative opportunity and proving the previous offering was worth the time and R&D to investors with good data will re-ignite excitement and investment. Although market conditions have been terrible lately, RGNX has held up great (I interpret this as positive sentiment going into data). I have outlined and noted bullish patterns I will be watching. One-Year-high : $85.10, July 09, 2018 Cup and Handle formation starting date of IPO (Stock has retraced to bullish .707 harmonic retracement level from the July 2018 high). Recent low of $30 has significant price structure to hold current support. $30 also marked "oversold" territory and double bottom on the one-year chart. Symmetrical patterns portray controlled accumulation/ distribution in downtrend. Recent price spikes indicate Bulls buying back in for potential run-up on good data. RSI and CCI moving toward positive slopes. Fibonnacci support levels converge with July 09, 2018 high. Levels to Watch -- Levels I will be watching to add range from current price ($35) down to $30.40 -- Structural levels (highlighted in horizontal rectangular box) -- Support levels (horizontal lines on chart) price needs to hold range from $30 -> $26 Please like and follow us here so I can continue finding awesome charts and money moves. Thanks in advance! Disclosure: I am long RGNX. I may buy or sell within the next 72 hours. This is not a recommendation to buy or sale, please do your homework before investing. Check my recent move with Conformis Inc. (Nasdaq: CFMS) , gaining over 30% move today
NASDAQ:RGNXLong
by follow_the_money
Gene Therapy for SMA-- Full technical analysis #VolatilityWatch RGNX and Novartis just received FDA approval of Gene Therapy treatment for Spinal Muscular Atrophy (SMA). (SMA)Spinal Muscular Atrophy is a disease affecting the motor nerve cells in the spinal cord, taking away the ability to walk, eat, or breathe. It is the number one genetic cause of death for infants. According to a company filling, price tag for treatment is $2.1 million. Product is called Zolgensma Congrats to RGNX and Novartis for the huge accomplishment! I am putting this on #VolatilityWatch Come Join our Biotech trading team! Twitter: @VolatilityWatch StockTwits: MS_Money_Moves Disclaimer : I currently do not own any position in RGNX. This is not advice to buy or sell, It is for educational purposes. Please do your homework before investing.
NASDAQ:RGNX
by follow_the_money